JNJ
33
-12
SLB
37
-4
RSG
53
3
DLTR
44
-6
HD
37
2
UNH
45
4
SIG
38
-3
PH
57
4
BDX
65
2
MAT
58
9
VTR
35
4
KSS
32
-2
STT
59
14
JCI
45
4
TROW
37
5
FE
44
3
EQT
56
2
K
65
2
VZ
27
3
ITW
33
2
JNJ
33
-12
SLB
37
-4
RSG
53
3
DLTR
44
-6
HD
37
2
UNH
45
4
SIG
38
-3
PH
57
4
BDX
65
2
MAT
58
9
VTR
35
4
KSS
32
-2
STT
59
14
JCI
45
4
TROW
37
5
FE
44
3
EQT
56
2
K
65
2
VZ
27
3
ITW
33
2
Financhill
Back

Offerpad Solutions Vs. Janux Therapeutics Industry Stock Comparison

Sell
21

OPAD
Offerpad Solutions

Last Price:
$2.59
Seasonality Move:
-9.03%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Sell
21
Offerpad Solutions (OPAD) is a Sell

Is Offerpad Solutions a Buy, Sell or Hold?

  • The current Offerpad Solutions [OPAD] share price is $2.56. The Score for OPAD is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • OPAD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

OPAD Stock Price Chart

What is Offerpad Solutions's stock price today?

  • The Offerpad Solutions share price today is $2.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OPAD is experiencing selling pressure, which indicates risk of future bearish movement.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

OPAD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.34 Sell
Relative Strength Index (14 RSI): 30.92 Sell
Chaikin Money Flow: -34754 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.89 - 4.21) Sell
Bollinger Bands (100): (3.08 - 4.2) Sell

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

OPAD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.82 Sell
20-day SMA: 3.34 Sell
50-day SMA: 3.65 Sell
200-day SMA: 4.65 Sell
8-day EMA: 2.84 Sell
20-day EMA: 3.22 Sell
50-day EMA: 3.53 Sell
200-day EMA: 4.93 Sell

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

Offerpad Solutions Earnings Growth & OPAD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and an increase next year of $0.38 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

Offerpad Solutions Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):